AMA: Administration Decision on Medicare Part D Will Benefit Patients

| 1 Min Read

Statement attributed to:

Barbara L. McAneny, M.D.

President, American Medical Association

“Seriously ill patients who faced the prospect of new hurdles to accessing their medication can breathe a sigh of relief now that the Trump administration has discarded the proposal. The American Medical Association commends the administration for recognizing its proposal to weaken coverage for six protected drug classes under Medicare Part D had potential dangers for patient health. The AMA and other patient champions detailed the potential effects of the policy, and we’re grateful the administration listened.

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Columns of the U.S. Supreme Court at top of steps

8 wins for doctors, patients in latest federal budget deal

| 4 Min Read
Wooden blocks and figures accompany an up arrow

Do physicians need to switch jobs to climb the career ladder?

| 5 Min Read
Physician walking down a hallway

Women physicians face heavier burdens and higher burnout risk

| 9 Min Read
Adhesive bandage applied to upper arm of smiling young patient

Pediatric vaccines: Questions parents will ask—and how to answer

| 8 Min Read